How can TheraLife Eye Help?
TheraLife Eye is effective in reducing inflammation and stimulates tear flow for chronic dry eye relief. Often people with chronic dry eyes also have blepharitis. Treating chronic dry eyes reduces the inflammation, and also helps to reduce the recurrence of blepharitis symptoms. It is highly recommended that those who have blepharitis stay on TheraLife Eye long term to increase the rate of success.
Do you have chronic dry eyes?
Your eyes are sore! They hurt!. You have been told you have chronic dry eyes
You are already using eye drops- feels like you have to put them in every 10 minutes!.
Here are some simple suggestions to help:
- Drink plenty of water – we recommend at least 8 glasses per day. Fruit juices are fine. Avoid caffeine from coffee or soda. Drink decaffeinated coffee as an alternative
- Exercise – at least three to four times per week. The more the better! Exercises improve circulation and help deliver blood and nutrients to the eye.
- Use humidifiers -either single portable units next to your desk or install it for your central air system. This is most helpful in winter or if you live in a dry, high altitude climate. Be sure to clean it often in order not to build up bacteria in the humidifier.
- Wear wrap around sunglasses outdoors – dry eyes are often light and wind sensitive.
- Avoid frequent use of eye drops- do you put eye drops in your eyes, and they feel dry again in 10 minutes? Eye drops wash away mucin, proteins and lipids that thicken your tears to prevent fast evaporation. Long-term use can condition your eyes not to secret tears and exacerbate the dry eye condition.
- Wear eye goggles at night – your eyelids maybe partially open during sleep – to test this, tape 2 wet cotton balls onto your eyes for one night and see if your dry eye condition improved when you wake up. If yes, you can buy a goggle to wear at night that contains moisture pads. We recommend TranquilEyes from eyeeco.com.
- Use warm compress over your eyes- to improve circulation and allow you to relax. For more information.
- Get enough sleep!
- Computer use -schedule frequent breaks and take your eyes away from the computer and look out the window every hour.
Is this information helpful? Forward to your friends!
Learn a new approach to treating Dry Eyes- by stimulating tear glands to secrete balanced, sustainable, natural tears from TheraLife. Go to: www.theralife.com/enhanced.html
Frequently Asked Questions
What is the best home remedy for dry eyes?
Best home remedies for dry eyes is to use artificial drops, use warm compresses, massage eyelids, and lid hygiene.
If these measures do not help, see your eye doctor to get proper diagnosis and treatment plan. Call a doctor at Theralife toll free 1-877-917-1989 US/Canada
How can I relieve my dry eyes?
You can relieve your dry eyes at home by doing web warm compresses, use eye drops, clean eyelids, use a humidifier, wear eye mask to bed. Want more information, visit TheraLife web site to learn more.
Does dry eye ever go away?
There is no cure for dry eyes, therefore dry eyes will not go away. However, we can manage your dry eye symptoms and get your life back on track. Seek help from TheraLife.
What is the main cause of dry eyes?
Main cause of dry eyes is aging. Women also get dry eyes due to menopause and aging. Take care of yourself for optimum eye health. Look for treatment from TheraLife.
Conclusion
Dry eye disease is a common condition that occurs when your tears aren’t able to provide adequate lubrication for your eyes. Tears can be inadequate and unstable for many reasons. For example, dry eyes may occur if you don’t produce enough tears or if you produce poor-quality tears. Treatments are available to make your life easier and prevent future vision problems.
References
The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007; 5: 93– 107.
Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017; 15: 334– 365.
Uchino M, Nishiwaki Y, Michikawa T, et al. Prevalence and risk factors of dry eye disease in Japan: Koumi study. Ophthalmology. 2011; 118: 2361– 2367.
Farrand KF, Fridman M, Stillman IO, Schaumberg DA. Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older. Am J Ophthalmol. 2017; 182: 90– 98.
Koh S. Mechanisms of visual disturbance in dry eye. Cornea. 2016; 35 (suppl 1): S83– S88.
Koh S, Maeda N, Hirohara Y, et al. Serial measurements of higher-order aberrations after blinking in patients with dry eye. Invest Ophthalmol Vis Sci. 2008; 49: 133– 138.
Koh S, Maeda N, Ikeda C, et al. Ocular forward light scattering and corneal backward light scattering in patients with dry eye. Invest Ophthalmol Vis Sci. 2014; 55: 6601– 6606.
Kaido M, Dogru M, Yamada M, et al. Functional visual acuity in Stevens-Johnson syndrome. Am J Ophthalmol. 2006; 142: 917– 922.
Kaido M, Yamada M, Sotozono C, et al. The relation between visual performance and clinical ocular manifestations in Stevens-Johnson syndrome. Am J Ophthalmol. 2012; 154: 499– 511.e1.
Bauskar A, Mack WJ, Mauris J, et al. Clusterin seals the ocular surface barrier in mouse dry eye. PLoS One. 2015; 10: e0138958.
Nakamura T, Nishida K, Dota A, Kinoshita S. Changes in conjunctival clusterin expression in severe ocular surface disease. Invest Ophthalmol Vis Sci. 2002; 43: 1702– 1707.
Jeong S, Ledee DR, Gordon GM, et al. Interaction of clusterin and matrix metalloproteinase-9 and its implication for epithelial homeostasis and inflammation. Am J Pathol. 2012; 180: 2028– 2039.
Stephens DN, McNamara NA. Altered mucin and glycoprotein expression in dry eye disease. Optom Vis Sci. 2015; 92: 931– 938.
Uchino Y, Uchino M, Yokoi N, et al. Alteration of tear mucin 5AC in office workers using visual display terminals: The Osaka Study. JAMA Ophthalmol. 2014; 132: 985– 992.
Argueso P, Balaram M, Spurr-Michaud S, Keutmann HT, Dana MR, Gipson IK. Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjogren syndrome. Invest Ophthalmol Vis Sci. 2002; 43: 1004– 1011.
Uchino Y, Woodward AM, Argueso P. Differential effect of rebamipide on transmembrane mucin biosynthesis in stratified ocular surface epithelial cells. Exp Eye Res. 2016; 153: 1– 7.
Uchino Y, Mauris J, Woodward AM, et al. Alteration of galectin-3 in tears of patients with dry eye disease. Am J Ophthalmol. 2015; 159: 1027– 1035.e3.
Geerling G, Baudouin C, Aragona P, et al. Emerging strategies for the diagnosis and treatment of meibomian gland dysfunction: Proceedings of the OCEAN group meeting. Ocul Surf. 2017; 15: 179– 192.
Arita R, Morishige N, Koh S, et al. Increased tear fluid production as a compensatory response to meibomian gland loss: a multicenter cross-sectional study. Ophthalmology. 2015; 122: 925– 933.
Goto E, Dogru M, Fukagawa K, et al. Successful tear lipid layer treatment for refractory dry eye in office workers by low-dose lipid application on the full-length eyelid margin. Am J Ophthalmol. 2006; 142: 264– 270.
Liu R, Rong B, Tu P, et al. Analysis of cytokine levels in tears and clinical correlations after intense pulsed light treating meibomian gland dysfunction. Am J Ophthalmol. 2017; 183: 81– 90.
Pflugfelder SC, de Paiva CS. The pathophysiology of dry eye disease: what we know and future directions for research. Ophthalmology 2017; 124: S4– S13.
Bron AJ, de Paiva CS, Chauhan SK, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017; 15: 438– 510.
Baudouin C. A new approach for better comprehension of diseases of the ocular surface [in French]. J Fr Ophtalmol. 2007; 30: 239– 246.
Rhee MK, Mah FS. Inflammation in dry eye disease: how do we break the cycle? Ophthalmology. 2017; 124: S14– S19.
Niederkorn JY, Stern ME, Pflugfelder SC, et al. Desiccating stress induces T cell-mediated Sjogren’s syndrome-like lacrimal keratoconjunctivitis. J Immunol. 2006; 176: 3950– 3957.
Strong B, Farley W, Stern ME, Pflugfelder SC. Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca. Cornea. 2005; 24: 80– 85.
Zhang X, Chen W, De Paiva CS, et al. Interferon-gamma exacerbates dry eye-induced apoptosis in conjunctiva through dual apoptotic pathways. Invest Ophthalmol Vis Sci. 2011; 52: 6279– 6285.
Chauhan SK, El Annan J, Ecoiffier T, et al. Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J Immunol. 2009; 182: 1247– 1252.
Chen Y, Chauhan SK, Shao C, Omoto M, Inomata T, Dana R. IFN-gamma-expressing Th17 cells are required for development of severe ocular surface autoimmunity. J Immunol. 2017; 199: 1163– 1169.
Pflugfelder SC, Huang AJ, Feuer W, Chuchovski PT, Pereira IC, Tseng SC. Conjunctival cytologic features of primary Sjögren’s syndrome. Ophthalmology. 1990; 97: 985– 991.
Raphael M, Bellefqih S, Piette JC, Le Hoang P, Debre P, Chomette G. Conjunctival biopsy in Sjögren’s syndrome: correlations between histological and immunohistochemical features. Histopathology. 1988; 13: 191– 202.
Hikichi T, Yoshida A, Tsubota K. Lymphocytic infiltration of the conjunctiva and the salivary gland in Sjogren’s syndrome. Arch Ophthalmol. 1993; 111: 21– 22.
Williamson J, Gibson AA, Wilson T, Forrester JV, Whaley K, Dick WC. Histology of the lacrimal gland in keratoconjunctivitis sicca. Br J Ophthalmol. 1973; 57: 852– 858.
Belfort RJr, Mendes NF. Identification of T and B lymphocytes in the human conjunctiva and lacrimal gland in ocular diseases. Br J Ophthalmol. 1980; 64: 217– 219.
Wakamatsu TH, Sato EA, Matsumoto Y, et al. Conjunctival in vivo confocal scanning laser microscopy in patients with Sjogren syndrome. Invest Ophthalmol Vis Sci. 2010; 51: 144– 150.
He J, Ogawa Y, Mukai S, et al. In vivo confocal microscopy evaluation of ocular surface with graft-versus-host disease-related dry eye disease. Sci Rep. 2017; 7: 10720.
Kheirkhah A, Rahimi Darabad R, Cruzat A, et al. Corneal epithelial immune dendritic cell alterations in subtypes of dry eye disease: a pilot in vivo confocal microscopic study. Invest Ophthalmol Vis Sci. 2015; 56: 7179– 7185.
Vera LS, Gueudry J, Delcampe A, Roujeau JC, Brasseur G, Muraine M. In vivo confocal microscopic evaluation of corneal changes in chronic Stevens-Johnson syndrome and toxic epidermal necrolysis. Cornea. 2009; 28: 401– 407.
Jones DT, Monroy D, Ji Z, Pflugfelder SC. Alterations of ocular surface gene expression in Sjogren’s syndrome. Adv Exp Med Biol. 1998; 438: 533– 536.
Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren’s syndrome keratoconjunctivitis sicca. Curr Eye Res. 1999; 19: 201– 211.
Barton K, Monroy DC, Nava A, Pflugfelder SC. Inflammatory cytokines in the tears of patients with ocular rosacea. Ophthalmology. 1997; 104: 1868– 1874.
Brignole F, Pisella PJ, Goldschild M, De Saint Jean M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci. 2000; 41: 1356– 1363.
Tsubota K, Fukagawa K, Fujihara T, et al. Regulation of human leukocyte antigen expression in human conjunctival epithelium. Invest Ophthalmol Vis Sci. 1999; 40: 28– 34.
Brignole F, Pisella PJ, De Saint Jean M, Goldschild M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. Invest Ophthalmol Vis Sci. 2001; 42: 90– 95.
Perez VL, Pflugfelder SC, Zhang S, Shojaei A, Haque R. Lifitegrast, a novel integrin antagonist for treatment of dry eye disease. Ocul Surf. 2016; 14: 207– 215.
Mastropasqua L, Nubile M, Lanzini M, et al. Epithelial dendritic cell distribution in normal and inflamed human cornea: in vivo confocal microscopy study. Am J Ophthalmol. 2006; 142: 736– 744.
Villani E, Baudouin C, Efron N, et al. In vivo confocal microscopy of the ocular surface: from bench to bedside. Curr Eye Res. 2014; 39: 213– 231.
Yamaguchi T, Calvacanti BM, Cruzat A, et al. Correlation between human tear cytokine levels and cellular corneal changes in patients with bacterial keratitis by in vivo confocal microscopy. Invest Ophthalmol Vis Sci. 2014; 55: 7457– 7466.
Lin H, Li W, Dong N, et al. Changes in corneal epithelial layer inflammatory cells in aqueous tear-deficient dry eye. Invest Ophthalmol Vis Sci. 2010; 51: 122– 128.
Villani E, Garoli E, Termine V, Pichi F, Ratiglia R, Nucci P. Corneal confocal microscopy in dry eye treated with corticosteroids. Optom Vis Sci. 2015; 92: e290– e295.
VanDerMeid KR, Su SP, Krenzer KL, Ward KW, Zhang JZ. A method to extract cytokines and matrix metalloproteinases from Schirmer strips and analyze using Luminex. Mol Vis. 2011; 17: 1056– 1063.
Jun AS, Cope L, Speck C, et al. Subnormal cytokine profile in the tear fluid of keratoconus patients. PLoS One. 2011; 6: e16437.
Lema I, Duran JA. Inflammatory molecules in the tears of patients with keratoconus. Ophthalmology. 2005; 112: 654– 659.
Riemens A, Stoyanova E, Rothova A, Kuiper J. Cytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation. Mol Vis. 2012; 18: 797– 802.
Leonardi A, Curnow SJ, Zhan H, Calder VL. Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. Clin Exp Allergy. 2006; 36: 777– 784.
Zakaria N, Van Grasdorff S, Wouters K, et al. Human tears reveal insights into corneal neovascularization. PLoS One. 2012; 7: e36451.
Lam H, Bleiden L, de Paiva CS, Farley W, Stern ME, Pflugfelder SC. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol. 2009; 147: 198– 205.e1.
Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001; 42: 2283– 2292.
Luo L, Li DQ, Corrales RM, Pflugfelder SC. Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. Eye Contact Lens. 2005; 31: 186– 193.
Villani E, Galimberti D, Del Papa N, Nucci P, Ratiglia R. Inflammation in dry eye associated with rheumatoid arthritis: cytokine and in vivo confocal microscopy study. Innate Immun. 2013; 19: 420– 427.
Lee H, Chung B, Kim KS, Seo KY, Choi BJ, Kim TI. Effects of topical loteprednol etabonate on tear cytokines and clinical outcomes in moderate and severe meibomian gland dysfunction: randomized clinical trial. Am J Ophthalmol. 2014; 158: 1172– 1183.e1.
Aketa N, Yamaguchi T, Asato T, et al. Elevated aqueous cytokine levels in eyes with ocular surface diseases. Am J Ophthalmol. 2017; 184: 42– 51.
Khanal S, Tomlinson A. Tear physiology in dry eye associated with chronic GVHD. Bone Marrow Transplant. 2012; 47: 115– 119.
Yuki K, Shimmura S, Shiba D, Tsubota K. End-stage glaucoma in Stevens-Johnson syndrome. Jpn J Ophthalmol. 2009; 53: 68– 70.Tsai JH, Derby E, Holland EJ, Khatana AK. Incidence and prevalence of glaucoma in severe ocular surface disease. Cornea. 2006; 25: 530– 532.
Shimazaki J, Shimmura S, Fujishima H, Tsubota K. Association of preoperative tear function with surgical outcome in severe Stevens-Johnson syndrome. Ophthalmology. 2000; 107: 1518– 1523.
Ang LP, Sotozono C, Koizumi N, Suzuki T, Inatomi T, Kinoshita S. A comparison between cultivated and conventional limbal stem cell transplantation for Stevens-Johnson syndrome. Am J Ophthalmol. 2007; 143: 178– 180.
Satici A, Guzey M, Dogan Z, Kilic A. Relationship between Tear TNF-alpha, TGF-beta1, and EGF levels and severity of conjunctival cicatrization in patients with inactive trachoma. Ophthalmic Res. 2003; 35: 301– 305.
Can I take these along with my other medication ?
Oromorph , zomorph , tramadol
Fiona
Yes, you can take TheraLife capsules with your other medications. No problem. Call me toll free 1-877-917-1989. Tell me more about your dry eyes.
hi lily
my eyes are dry and sore and itcy all the time they start watering when cold
I want to start scratching them well my eye lids when closed they are irritating all the time when itching
Barry
See my response to you above. I would like to talk to you. Call me 1-877-917-1989
hi lily
my eyes are sore and itchy they feel dry all the time it is very irritating and when cold they start to water
Barry- The reason why your eyes started to water is because you have had dry eyes for a long time. Now your brain is trying to help you provide moisture by crying. We can stop this watery eyes. You need to start taking TheraLife Eye capsules to restore your tear function. Once your eyes are no longer dry, your eyes will stop watering. I recommend you start with the chronic dry eye starter kit. Click here. . Any questions, call us toll free 1-877-917-1989 US/Canada
I have been suffering for years. My light sensitivity has gotten worse since I had conjustoplasty last year. My eyes feel very dry. I find that I want to keep them closed more than I want to keep them open. Now I feel like that has become a bad habit. I also keep rubbing my eyes which has become another bad habit. I definitely feel like this is worse! I feel debilitated and pathetic. I have spent thousands between products and doctors and nothing is working. I need to have my life back and to open my eyes like a normal person
Mr Suponski
What you are described are typical chronic dry eye symptoms. TheraLife Eye capsules are designed for people like you. It restores and revives your tear secretion glands so you make your own tears. No more eye drops. Please call me toll free 1-877-917-1989. Here is a story from one of our customers you might be interested in.
Chronic Dry Eye Relief- TheraLife.
I would like to thank you for the products (for dry eyes) that I have ordered and used.
I can say that your product work wonders on my eyes. I have chronic dry eye syndrome and have been so disappointed with eye drops that other doctors prescribed.
But finally, TheraLife came into my life. It is now my number 1 (one) miracle worker!!!!
I will be writing my reviews on Yelp and your FB account soon. I love what your product has done for my eyes. Truly Amazing!!!
Let me reiterate. Thank you so much for your product, Dr. Yang!!!
Sincerely,
Celeste H Wilkinson